Show simple item record

AuthorKodura, Magdalena Anna
AuthorSouchelnytskyi, Serhiy
Available date2019-02-13T10:27:41Z
Publication Date2015-12-01
Publication NameCancer and Metastasis Reviewsen_US
CitationKodura MA, Souchelnytskyi S. Breast carcinoma metastasis suppressor gene 1 (BRMS1): update on its role as the suppressor of cancer metastases. Cancer Metastasis Rev. 2015 Dec;34(4):611-8. doi: 10.1007/s10555-015-9583-z.
AbstractBRMS1 was discovered over a decade ago as a potential tumor suppressor gene. In this review, we summarize the recent findings about the structure of BRMS1, mechanisms of its action and a role of BRMS1 in the cancer progression. As a suppressor of metastasis, BRMS1 has demonstrated a variety of ways to act on the cell functions, such as cell migration, invasiveness, angiogenesis, cell survival, cytoskeleton rearrangements, cell adhesion, and immune recognition. This variety of effects is a likely reason behind the robustness of anti-metastatic influence of BRMS1. Intracellular signaling mechanisms employed by BRMS1 include regulation of transcription, EGF/HER2 signaling, and expression of NF-kB, fascin, osteopontin, and IL-6. Recently reported clinical studies confirm that BRMS1 can indeed be used as a prognostic marker. Approaches to employ BRMS1 in a development of anti-cancer treatment have also been made. The studies reviewed here with respect to BRMS1 structure, cellular effects, intracellular signaling, and clinical value consolidate the importance of BRMS1 in the development of metastasis.
SponsorNPRP9-453-3-089, QU internal grants
Subjectcancer, BRMS1
TitleBreast carcinoma metastasis suppressor gene 1 (BRMS1): update on its role as the suppressor of cancer metastases.
Issue Number4
Volume Number34
dc.identifier.essn 1573-7233

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record